Table 1.
Functions and diseases associated with NFAT family members.
Isoform |
|
Involvement in Organ/Tissue Formation or Cell Function | Abnormal NFAT Activity | |
---|---|---|---|---|
Human | Knockout Mouse | |||
NFATc1 |
|
Heart valve/septum formation [5,17], angiogenesis [32,33], osteoclast formation [28], T cell proliferation/Th2 differentiation [82,83] | Pancreatic cancer [31], colon cancer (increased risk of metastasis) [36], leukemia [35,37], lymphoma [39] | Embryonic lethality (circulatory failure) [5] |
NFATc2 | Cell cycle arrest/cell growth inhibition (normal cells) [26,41], activation-induced cell death [59], regulation of angiogenesis [45] | Pancreatic cancer [44], lung adenocarcinoma (> stage II) [43], mild cognitive impairment [50] | Increased immune reactivity [21,22], allergic contact hypersensitivity [59], lymphoma [42], lymphocyte hyperplasia (NFATc2/c3 DKO) [53], | |
NFATc3 | - | Lung squamous cell carcinoma (well-differentiated cancer) [43], glioma [46] | lymphocyte hyperplasia (NFATc2/c3 DKO) [53], embryonic lethality (vascular hypoplasia, NFATc3/c4 DKO) [18] | |
NFATc4 | Nervous system assembly/spatial memory formation [6,23] |
Skin cancer [47], severe cognitive impairment [50], Alzheimer’s disease [50] | Spatial memory dysplasia [23], embryonic lethality (vascular hypoplasia, NFATc3/c4 DKO) [18] | |
NFAT5 |
|
Cell protection under hypertonic stress [8], homeostasis [9] | Rheumatoid arthritis [63] | Mostly embryonic lethality (decreased cardiac function, renal atrophy) [19,20] |
DKO: double knock-out.